journal article·2023-12-04

Redox-Induced Ostwald Ripening of Ultrasmall Gold Nanoparticles for H2O2-Activated Photoacoustic Imaging

Chunyu Zhou, Tao Sun, Qian Xie, Liang Zhang, Wansu Zhang, Miaomiao Wang, Mingfu Gong, Dong Zhang

ACS Materials Letters· Volume 5· Issue 12
Publisher page

Abstract

Microenvironment-responsive imaging has tremendous application potential in disease diagnosis. Elevated levels of hydrogen peroxide (H 2 O 2 ) have been observed in tumor and inflammation tissues, making it an ideal endogenous molecule for microenvironment-activated diagnostics. In this study, we prepared an activatable plasmonic theranostics system based on silica-carried ultrasmall gold nanoparticles (SiO 2 @usAu NPs). The SiO 2 @usAu NPs underwent an Ostwald ripening process in response to the overexpressed H 2 O 2 in the microenvironment. A red shift in the ultraviolet–visible light (UV-vis) absorption spectrum was observed after the Ostwald redox reaction, transitioning from the UV-vis to near-infrared (IR) region, accompanied by an augmentation in the size of the gold nanoparticles. With the H 2 O 2 -activated characteristics, SiO 2 @usAu NPs are considered to be a suitable responsive photoacoustic imaging contrast agent. Furthermore, in vivo experiments demonstrate that the SiO 2 @usAu NPs showed good in vivo photoacoustic imaging performance both in the 4T1 tumor model and the LPS-induced peritonitis model, suggesting that it could be used as a responsive photoacoustic imaging contrast agent for noninvasive detection and diagnosis of diseases in vivo, including cancers and inflammation-related diseases with exceptional sensitivity and precision. The remarkable microenvironment-responsive characteristics of SiO 2 @usAu NPs offer novel prospects for the advancement of light-regulated nanoplatforms for noninvasive and accurate diagnosis.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Photoacoustic and Ultrasonic Imaging · Nanoplatforms for cancer theranostics · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Radiology, Xinqiao Hospital, Army Medical University, Chongqing 400037, People’s Republic of China

Faculty of Materials Science and Chemistry, China University of Geosciences, Wuhan 430074, People’s Republic of China

Funding

Army Medical University · Natural Science Foundation of Chongqing Municipality · National Natural Science Foundation of China · Talent Project of Chongqing

References (48)

Show source-provided references
1. 10.1073/pnas.170197611410.1073/pnas.1701976114 ↗
2. 10.1021/ac400659u10.1021/ac400659u ↗
3. 10.1038/nchembio.8510.1038/nchembio.85 ↗
4. 10.1038/nature0598510.1038/nature05985 ↗
5. 10.1073/pnas.101286410710.1073/pnas.1012864107 ↗
6. 10.1021/acs.nanolett.1c0019710.1021/acs.nanolett.1c00197 ↗
7. 10.1021/acs.analchem.2c0205210.1021/acs.analchem.2c02052 ↗
8. 10.1016/j.actbio.2021.12.01310.1016/j.actbio.2021.12.013 ↗
9. 10.7150/thno.1587810.7150/thno.15878 ↗
10. 10.1038/nmeth.392910.1038/nmeth.3929 ↗
11. 10.1016/j.tibtech.2011.01.00610.1016/j.tibtech.2011.01.006 ↗
12. 10.1021/acsnano.9b0454110.1021/acsnano.9b04541 ↗
13. 10.1016/j.tibtech.2016.02.00110.1016/j.tibtech.2016.02.001 ↗
14. 10.1126/science.121621010.1126/science.1216210 ↗
15. 10.1021/acsnano.9b0141110.1021/acsnano.9b01411 ↗
16. 10.1002/adma.20170750910.1002/adma.201707509 ↗
17. 10.1038/nmeth.392510.1038/nmeth.3925 ↗
18. 10.1098/rsfs.2011.002810.1098/rsfs.2011.0028 ↗
19. 10.1038/s41467-017-00598-110.1038/s41467-017-00598-1 ↗
20. 10.1002/anie.20200178310.1002/anie.202001783 ↗
21. 10.1016/j.cej.2022.13988810.1016/j.cej.2022.139888 ↗
22. 10.1021/acs.analchem.0c0460110.1021/acs.analchem.0c04601 ↗
23. 10.1021/acsabm.0c0142810.1021/acsabm.0c01428 ↗
24. 10.1002/cmmi.43910.1002/cmmi.439 ↗
25. 10.1002/adma.20200653210.1002/adma.202006532 ↗
26. 10.1038/s41565-019-0392-310.1038/s41565-019-0392-3 ↗
27. 10.1007/s12274-020-3000-910.1007/s12274-020-3000-9 ↗
28. 10.1002/adma.20190288510.1002/adma.201902885 ↗
29. 10.1021/acs.nanolett.8b0370910.1021/acs.nanolett.8b03709 ↗
30. 10.1016/j.ijpharm.2022.12252910.1016/j.ijpharm.2022.122529 ↗
31. 10.1016/j.actbio.2021.05.00710.1016/j.actbio.2021.05.007 ↗
32. 10.3389/fchem.2017.0011810.3389/fchem.2017.00118 ↗
33. 10.1002/smll.20220640810.1002/smll.202206408 ↗
34. 10.1021/nn502349k10.1021/nn502349k ↗
35. 10.1016/j.ijhydene.2009.08.08710.1016/j.ijhydene.2009.08.087 ↗
36. 10.1039/C5DT02964C10.1039/C5DT02964C ↗
37. 10.1002/apj.46110.1002/apj.461 ↗
38. 10.1039/C5CC07957H10.1039/C5CC07957H ↗
39. 10.1021/la302780410.1021/la3027804 ↗
40. 10.1021/cg201243n10.1021/cg201243n ↗
41. 10.1007/s10555-010-9224-510.1007/s10555-010-9224-5 ↗
42. 10.1002/adma.20160190210.1002/adma.201601902 ↗
43. Szatrowski T. P. · Cancer Res. · 1991 · 51 · 794
44. 10.1016/j.chempr.2017.10.00210.1016/j.chempr.2017.10.002 ↗
45. 10.1002/adma.20190288510.1002/adma.201902885 ↗
46. 10.1111/j.1365-2249.2006.03261.x10.1111/j.1365-2249.2006.03261.x ↗
47. 10.1056/NEJMra04343010.1056/NEJMra043430 ↗
48. 10.1179/096805106X11882510.1179/096805106X118825 ↗